NCT06186388View on ClinicalTrials.gov

Glaucoma Screening

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 5, 2023

Primary Completion Date

May 15, 2024

Study Completion Date

May 15, 2024

Conditions
Glaucoma
Interventions
DIAGNOSTIC_TEST

TEMPO iMOvifa

Screening test with 28 testing points

Trial Locations (1)

28412

Cape Fear Eye Institute, Wilmington

All Listed Sponsors
lead

Cape Fear Eye Institute

OTHER

NCT06186388 - Glaucoma Screening | Biotech Hunter | Biotech Hunter